112 related articles for article (PubMed ID: 18708918)
1. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5.
Brower RS; Vickroy NM
Spine (Phila Pa 1976); 2008 Aug; 33(18):E653-5. PubMed ID: 18708918
[TBL] [Abstract][Full Text] [Related]
2. Brower RS, Vickrov NM. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 2008;33:E653-55.
Dickerman RD; Reynolds AS; Bennett M
Spine (Phila Pa 1976); 2009 Apr; 34(7):749; author reply 749. PubMed ID: 19333110
[No Abstract] [Full Text] [Related]
3. Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation.
Taher F; Lebl DR; Hughes AP; Girardi FP
Spine J; 2013 Feb; 13(2):e1-5. PubMed ID: 23321149
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion.
Aichmair A; Girardi FP; Hughes AP; Sama AA; Lebl DR; Cammisa FP
Spine J; 2013 Oct; 13(10):1411-2. PubMed ID: 24139750
[No Abstract] [Full Text] [Related]
5. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion.
Christensen TJ; Annis P; Hohl JB; Patel AA
Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359
[TBL] [Abstract][Full Text] [Related]
6. Acute epidural lipedema: a novel entity and potential complication of bone morphogenetic protein use in lumbar spine fusion.
Merrick MT; Hamilton KD; Russo SS
Spine J; 2013 Oct; 13(10):e15-9. PubMed ID: 23800822
[TBL] [Abstract][Full Text] [Related]
7. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
8. Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral lumbar spine fusion: a case report.
Anderson CL; Whitaker MC
Spine (Phila Pa 1976); 2012 Apr; 37(8):E502-6. PubMed ID: 22020605
[TBL] [Abstract][Full Text] [Related]
9. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
Mannion RJ; Nowitzke AM; Wood MJ
Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
11. Polyelectrolyte Complex Carrier Enhances Therapeutic Efficiency and Safety Profile of Bone Morphogenetic Protein-2 in Porcine Lumbar Interbody Fusion Model.
Wang M; Abbah SA; Hu T; Lam RW; Toh SY; Liu T; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine (Phila Pa 1976); 2015 Jul; 40(13):964-73. PubMed ID: 25893351
[TBL] [Abstract][Full Text] [Related]
12. Bilateral pedicle stress fracture after instrumented posterolateral lumbar fusion: a case report.
Ha KY; Kim YH
Spine (Phila Pa 1976); 2003 Apr; 28(8):E158-60. PubMed ID: 12698135
[TBL] [Abstract][Full Text] [Related]
13. Heparin-Based Polyelectrolyte Complex Enhances the Therapeutic Efficacy of Bone Morphogenetic Protein-2 for Posterolateral Fusion in a Large Animal Model.
Wang M; Lam RWM; Abbah SA; Hu T; Toh SY; Cool S; Bhakoo K; Li J; Goh JCH; Wong HK
Spine (Phila Pa 1976); 2016 Aug; 41(15):1199-1207. PubMed ID: 26953670
[TBL] [Abstract][Full Text] [Related]
14. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
Hoffmann MF; Jones CB; Sietsema DL
Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
[TBL] [Abstract][Full Text] [Related]
15. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
16. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis.
Joseph V; Rampersaud YR
Spine (Phila Pa 1976); 2007 Dec; 32(25):2885-90. PubMed ID: 18246013
[TBL] [Abstract][Full Text] [Related]
17. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
[TBL] [Abstract][Full Text] [Related]
18. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
[TBL] [Abstract][Full Text] [Related]
19. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
[TBL] [Abstract][Full Text] [Related]
20. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases.
Lewandrowski KU; Nanson C; Calderon R
Spine J; 2007; 7(5):609-14. PubMed ID: 17526434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
